Deccan Health Care Intrinsic Value
DECCAN Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹17.76 | ₹14.21 - ₹21.31 | +20.3% | EPS: ₹1.48, Sector P/E: 12x |
| Book Value Method | asset | ₹36.90 | ₹33.21 - ₹40.59 | +150.0% | Book Value/Share: ₹46.09, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹29.22 | ₹26.30 - ₹32.14 | +98.0% | Revenue/Share: ₹36.52, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹20.87 | ₹18.78 - ₹22.96 | +41.4% | EBITDA: ₹8.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹9.47 | ₹8.52 - ₹10.42 | -35.8% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹12.20 | ₹10.98 - ₹13.42 | -17.3% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹39.18 | ₹35.26 - ₹43.10 | +165.4% | EPS: ₹1.48, BVPS: ₹46.09 |
Want to compare with current market value? Check DECCAN share price latest .
Valuation Comparison Chart
DECCAN Intrinsic Value Analysis
What is the intrinsic value of DECCAN?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Deccan Health Care (DECCAN) is ₹20.87 (median value). With the current market price of ₹14.76, this represents a +41.4% variance from our estimated fair value.
The valuation range spans from ₹9.47 to ₹39.18, indicating ₹9.47 - ₹39.18.
Is DECCAN undervalued or overvalued?
Based on our multi-method analysis, Deccan Health Care (DECCAN) appears to be trading below calculated value by approximately 41.4%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 35.33 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.18 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 3.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.67x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Deccan Health Care
Additional stock information and data for DECCAN
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-13 Cr | ₹-13 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-7 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |